The association between rs1893217, rs478582 in PTPN2 and T1D risk with different diagnosed age, and related clinical characteristics in Chinese Han population

References

• Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014;383:69–82.
   PubMed Web of Science ®Google Scholar
• Dabelea D. The accelerating epidemic of childhood diabetes. Lancet. 2009;373:1999–2000.
   PubMed Web of Science ®Google Scholar
• Imperatore G, Boyle JP, Thompson TJ, et al. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care. 2012; 35:2515–2520.
   PubMed Web of Science ®Google Scholar
• Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes. 2002;51:3353–3361.
   PubMed Web of Science ®Google Scholar
• Redondo MJ, Steck AK, Pugliese A. Genetics of type 1 diabetes. Pediatr Diabetes. 2018;19:346–353.
   PubMed Web of Science ®Google Scholar
• Pociot F, Lernmark A. Genetic risk factors for type 1 diabetes. Lancet. 2016;387:2331–2339.
   PubMed Web of Science ®Google Scholar
• Smith MJ, Rihanek M, Wasserfall C, et al. Loss of B-cell anergy in type 1 diabetes is associated with high-risk HLA and non-HLA disease susceptibility alleles. Diabetes. 2018;67:697–703.
   PubMedGoogle Scholar
• Wiede F, Dudakov JA, Lu KH, et al. PTPN2 regulates T cell lineage commitment and alphabeta versus gammadelta specification. J Exp Med. 2017;214:2733–2758.
   PubMed Web of Science ®Google Scholar
• Spalinger MR, Kasper S, Chassard C, et al. PTPN2 controls differentiation of CD4(+) T cells and limits intestinal inflammation and intestinal dysbiosis. Mucosal Immunol. 2015;8:918–929.
   PubMed Web of Science ®Google Scholar
• Wiede F, Sacirbegovic F, Leong YA, et al. PTPN2-deficiency exacerbates T follicular helper cell and B cell responses and promotes the development of autoimmunity. J Autoimmun. 2017;76:85–100.
   PubMed Web of Science ®Google Scholar
• ten Hoeve J, de Jesus Ibarra-Sanchez M, Fu Y, et al. Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol Cell Biol. 2002;22:5662–5668.
   PubMed Web of Science ®Google Scholar
• Moore F, Colli ML, Cnop M, et al. PTPN2, a candidate gene for type 1 diabetes, modulates interferon-gamma-induced pancreatic beta-cell apoptosis. Diabetes. 2009;58:1283–1291.
   PubMed Web of Science ®Google Scholar
• Santin I, Moore F, Colli ML, et al. PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic β-cell apoptosis via regulation of the BH3-only protein Bim. Diabetes. 2011;60:3279–3288.
   PubMed Web of Science ®Google Scholar
• Marroqui L, Santin I, Dos Santos RS, et al. BACH2, a candidate risk gene for type 1 diabetes, regulates apoptosis in pancreatic β-cells via JNK1 modulation and crosstalk with the candidate gene PTPN2. Diabetes. 2014;63:2516–2527.
   PubMed Web of Science ®Google Scholar
• Yilmaz B, Spalinger MR, Biedermann L, et al. The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients. PLoS One. 2018;13:e0199664.
   PubMed Web of Science ®Google Scholar
• Eyre S, Bowes J, Diogo D, et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet. 2012;44:1336–1340.
   PubMed Web of Science ®Google Scholar
• Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007;39:857–864.
   PubMed Web of Science ®Google Scholar
• Long SA, Cerosaletti K, Wan JY, et al. An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4(+) T cells. Genes Immun. 2011;12:116–125.
   PubMed Web of Science ®Google Scholar
• Barrett JC, Clayton DG, Concannon P, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009;41:703–707.
   PubMed Web of Science ®Google Scholar
• Kiani AK, John P, Bhatti A, et al. Association of 32 type 1 diabetes risk loci in Pakistani patients. Diabetes Res Clin Pract. 2015;108:137–142.
   PubMed Web of Science ®Google Scholar
• Espino-Paisan L, de la Calle H, Fernandez-Arquero M, et al. A polymorphism in PTPN2 gene is associated with an earlier onset of type 1 diabetes. Immunogenetics. 2011;63:255–258.
   PubMed Web of Science ®Google Scholar
• Rheinheimer J, Oliveira F. d S d, Canani LH, et al. The rs1893217 (T/C) polymorphism in PTPN2 gene is not associated with type 1 diabetes mellitus in subjects from Southern Brazil. Arq Bras Endocrinol Metabol. 2014;58:382–388.
   PubMedGoogle Scholar
• Peng H, Li J, Chen X, et al. Genetic Variants of PTPN2 gene in chinese children with type 1 diabetes mellitus. Med Sci Monit. 2015;21:2653–2658.
   PubMed Web of Science ®Google Scholar
• Thomas NJ, Jones SE, Weedon MN, et al. Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol. 2018;6:122–129.
   PubMed Web of Science ®Google Scholar
• Weng J, Zhou Z, Guo L, et al. T1D China Study Group. Incidence of type 1 diabetes in China, 2010-13: population based study. BMJ. 2018;360:j5295.
   PubMedGoogle Scholar
• Plagnol V, Howson JM, Smyth DJ, et al. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet. 2011; 7:e1002216.
   PubMed Web of Science ®Google Scholar
• Lempainen J, Harkonen T, Laine A, et al. Associations of polymorphisms in non-HLA loci with autoantibodies at the diagnosis of type 1 diabetes: INS and IKZF4 associate with insulin autoantibodies. Pediatr Diabetes. 2013;14:490–496.
   PubMed Web of Science ®Google Scholar
• Steck AK, Wong R, Wagner B, et al. Effects of non-HLA gene polymorphisms on development of islet autoimmunity and type 1 diabetes in a population with high-risk HLA-DR,DQ genotypes. Diabetes. 2012; 61:753–758.
   PubMed Web of Science ®Google Scholar
• Andersen ML, Rasmussen MA, Pörksen S, et al. Complex multi-block analysis identifies new immunologic and genetic disease progression patterns associated with the residual beta-cell function 1 year after diagnosis of type 1 diabetes. PLoS One. 2013; 8:e64632.
   PubMed Web of Science ®Google Scholar
• Doody KM, Bourdeau A, Tremblay ML. T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease. Immunol Rev. 2009;228:325–341.
   PubMed Web of Science ®Google Scholar
• Yang JH, Cutler AJ, Ferreira RC, et al. Natural variation in interleukin-2 sensitivity influences regulatory T-cell frequency and function in individuals with long-standing type 1 diabetes. Diabetes. 2015;64:3891–3902.
   PubMed Web of Science ®Google Scholar
• Zhernakova DV, Deelen P, Vermaat M, et al. Identification of context-dependent expression quantitative trait loci in whole blood. Nat Genet. 2017;49:139–145.
   PubMed Web of Science ®Google Scholar
• Lempainen J, Laine AP, Hammais A, et al. Non-HLA gene effects on the disease process of type 1 diabetes: from HLA susceptibility to overt disease. J Autoimmun. 2015;61:45–53.
   PubMed Web of Science ®Google Scholar
• Petrone A, Spoletini M, Zampetti S, Immunotherapy Diabetes (IMDIAB) Group, et al. The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control. Diabetes Care. 2008;31:1214–1218.
   PubMed Web of Science ®Google Scholar
• Xi Y, Liu S, Bettaieb A, et al. Pancreatic T cell protein-tyrosine phosphatase deficiency affects beta cell function in mice. Diabetologia. 2015;58:122–131.
   PubMed Web of Science ®Google Scholar